ISPC

ISPC

iSpecimen Inc

iSpecimen Inc. operates an online marketplace connecting life science researchers with sources of human biospecimens, including biofluids, solid tissues, and hematopoietic stem cells. Its clients include biopharmaceutical companies and academic institutions.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-31.87%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-52.14%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score1.7
Net Growth-54.33%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth-91.71%
Rev TrendNever
Revenue Consistencyโ€”
All Time
Score
Net Growth-54.33%
Net Trend20%
Net Income Consistency
Rev Growth-91.71%
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

iSpecimen Inc fundamental performance

Across iSpecimen Inc's full reported history, from 2021 to 2025, revenue declined from $ 11M to $ 1M and net income went from -$ 8M to -$ 10M. Revenue increased in 0% of the years measured; net income in 20%.

iSpecimen Inc currently holds a 5-year HDB Score of 1.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 2.27โ€”
1 Year2025-08-12
$ 46.00-95.07%
5 Years2021-08-12
$ 5.04K-99.95%
All Time2021-06-17
$ 5.72K-99.96%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 923.25K-$ 13M$ 6M
2025$ 1M-$ 10M$ 6M
2024$ 9M-$ 12M$ 1M
2023$ 9M-$ 11M$ 5M
2022$ 10M-$ 10M$ 15M
IPO2021$ 11M-$ 8M$ 27M

Explore beyond ISPC

You're looking at iSpecimen Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies